Cellular Adoptive Immunotherapy Using Autologous Tumor-Infiltrating Lymphocytes Following Lymphodepletion With Cyclophosphamide and Fludarabine For Patients With Metastatic Melanoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aldesleukin; Cyclophosphamide; Fludarabine; Tumour infiltrating lymphocytes
- Indications Malignant melanoma
- Focus Therapeutic Use
- 02 Jul 2021 Biomarkers information updated
- 01 Jul 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 18 Mar 2013 New trial record